BBSRC | How BBSRC ICURe helped my spinout succeed @bbsrcmedia | Uploaded November 2023 | Updated October 2024, 3 hours ago.
The BBSRC Innovation to Commercialisation of University Research (ICURe) programme trains, funds, and supports research teams to determine whether there is a market for products or services that utilise their bioscience-based ideas, research, science, and technologies.
This opportunity is open to a range of applicants, including:
• research technicians and technology and skills specialists
• PhD students
• discovery Fellows and group leaders
• postdocs and early career researchers
Dr James Gavin used ICURe to commercially apply his research in bioengineered extracellular vesicles leading to a later Innovate UK spin-out, EVolution Therapeutics. Watch the video to hear from him and Professor Andrew Devitt, who advised on the project, on their success.
More about ICURe: icureprogramme.com
The BBSRC Innovation to Commercialisation of University Research (ICURe) programme trains, funds, and supports research teams to determine whether there is a market for products or services that utilise their bioscience-based ideas, research, science, and technologies.
This opportunity is open to a range of applicants, including:
• research technicians and technology and skills specialists
• PhD students
• discovery Fellows and group leaders
• postdocs and early career researchers
Dr James Gavin used ICURe to commercially apply his research in bioengineered extracellular vesicles leading to a later Innovate UK spin-out, EVolution Therapeutics. Watch the video to hear from him and Professor Andrew Devitt, who advised on the project, on their success.
More about ICURe: icureprogramme.com
